Next Article in Journal
Inhibition of Mild Steel Corrosion in Sulfuric Acid Solution by New Schiff Base
Previous Article in Journal
Shape Memory Properties of PBS-Silica Hybrids
Open AccessReview

Biocompatibility of Coronary Stents

The Heart Research Institute, Sydney NSW 2042, Australia
Sydney Medical School, University of Sydney, Sydney NSW 2006, Australia
School of Molecular Bioscience, University of Sydney, Sydney NSW 2006, Australia
Department of Cardiology, Royal Prince Alfred Hospital, University of Sydney, Sydney NSW 2050, Australia
Author to whom correspondence should be addressed.
Materials 2014, 7(2), 769-786;
Received: 24 December 2013 / Revised: 20 January 2014 / Accepted: 20 January 2014 / Published: 28 January 2014
(This article belongs to the Section Biomaterials)
Cardiovascular disease is the dominant cause of mortality in developed countries, with coronary artery disease (CAD) a predominant contributor. The development of stents to treat CAD was a significant innovation, facilitating effective percutaneous coronary revascularization. Coronary stents have evolved from bare metal compositions, to incorporate advances in pharmacological therapy in what are now known as drug eluting stents (DES). Deployment of a stent overcomes some limitations of balloon angioplasty alone, but provides an acute stimulus for thrombus formation and promotes neointimal hyperplasia. First generation DES effectively reduced in-stent restenosis, but profoundly delay healing and are susceptible to late stent thrombosis, leading to significant clinical complications in the long term. This review characterizes the development of coronary stents, detailing the incremental improvements, which aim to attenuate the major clinical complications of thrombosis and restenosis. Despite these enhancements, coronary stents remain fundamentally incompatible with the vasculature, an issue which has largely gone unaddressed. We highlight the latest modifications and research directions that promise to more holistically design coronary implants that are truly biocompatible. View Full-Text
Keywords: coronary artery disease; biofunctionalization; stent; thrombosis; restenosis coronary artery disease; biofunctionalization; stent; thrombosis; restenosis
MDPI and ACS Style

Jeewandara, T.M.; Wise, S.G.; Ng, M.K.C. Biocompatibility of Coronary Stents. Materials 2014, 7, 769-786.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop